163 related articles for article (PubMed ID: 25714535)
1. Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV).
Shiroma HF; Farah ME; Takahashi WY; Gomes AM; Goldbaum M; Rodrigues EB
Arq Bras Oftalmol; 2015; 78(1):32-5. PubMed ID: 25714535
[TBL] [Abstract][Full Text] [Related]
2. Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada.
Xing L; Dorrepaal SJ; Gale J
Can J Ophthalmol; 2014 Jun; 49(3):261-6. PubMed ID: 24862772
[TBL] [Abstract][Full Text] [Related]
3. Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting.
Hasler PW; Bloch SB; Villumsen J; Fuchs J; Lund-Andersen H; Larsen M
Acta Ophthalmol; 2015 Mar; 93(2):122-5. PubMed ID: 25403735
[TBL] [Abstract][Full Text] [Related]
4. National survey of the ophthalmic use of anti-vascular endothelial growth factor drugs in Israel.
Waisbourd M; Goldstein M; Loewenstein A
Isr Med Assoc J; 2011 Mar; 13(3):141-6. PubMed ID: 21608333
[TBL] [Abstract][Full Text] [Related]
5. Endophthalmitis after resident-performed intravitreal bevacizumab injection.
Falavarjani KG; Aghamirsalim M; Modarres M; Hadavandkhani A; Hashemi M; Parvaresh MM; Naseripour M; Samiy N
Can J Ophthalmol; 2015 Feb; 50(1):33-6. PubMed ID: 25677280
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
[TBL] [Abstract][Full Text] [Related]
7. Bimanual assisted eyelid retraction technique for intravitreal injections.
Fineman MS; Hsu J; Spirn MJ; Kaiser RS
Retina; 2013 Oct; 33(9):1968-70. PubMed ID: 23609121
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
9. Routes for Drug Delivery to the Eye and Retina: Intravitreal Injections.
Meyer CH; Krohne TU; Charbel Issa P; Liu Z; Holz FG
Dev Ophthalmol; 2016; 55():63-70. PubMed ID: 26501462
[TBL] [Abstract][Full Text] [Related]
10. A survey of UK practice patterns in the delivery of intravitreal injections.
Samia-Aly E; Cassels-Brown A; Morris DS; Stancliffe R; Somner JE
Ophthalmic Physiol Opt; 2015 Jul; 35(4):450-4. PubMed ID: 26094833
[TBL] [Abstract][Full Text] [Related]
11. Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon.
Bhavsar AR; Sandler DR
Retina; 2015 Apr; 35(4):783-8. PubMed ID: 25526099
[TBL] [Abstract][Full Text] [Related]
12. Characterization of sterile intraocular inflammatory responses after intravitreal bevacizumab injection.
Chong DY; Anand R; Williams PD; Qureshi JA; Callanan DG
Retina; 2010 Oct; 30(9):1432-40. PubMed ID: 20559156
[TBL] [Abstract][Full Text] [Related]
13. Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients.
Matthews JL; Dubovy SR; Goldberg RA; Flynn HW
Ophthalmology; 2014 Mar; 121(3):702-8. PubMed ID: 24439760
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal injections: is there benefit for a theatre setting?
Abell RG; Kerr NM; Allen P; Vote BJ
Br J Ophthalmol; 2012 Dec; 96(12):1474-8. PubMed ID: 23018424
[TBL] [Abstract][Full Text] [Related]
15. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection.
Mason JO; White MF; Feist RM; Thomley ML; Albert MA; Persaud TO; Yunker JJ; Vail RS
Retina; 2008 Apr; 28(4):564-7. PubMed ID: 18398358
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of anesthetic methods for intravitreal injections.
Blaha GR; Tilton EP; Barouch FC; Marx JL
Retina; 2011 Mar; 31(3):535-9. PubMed ID: 21102369
[TBL] [Abstract][Full Text] [Related]
17. No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting.
Brynskov T; Kemp H; Sørensen TL
Retina; 2014 May; 34(5):951-7. PubMed ID: 24317292
[TBL] [Abstract][Full Text] [Related]
18. [Azithromycin in prophylaxis of intravitreal injections in patients with wet age-related macular degeneration].
Figurska M
Klin Oczna; 2011; 113(1-3):38-41. PubMed ID: 21853949
[TBL] [Abstract][Full Text] [Related]
19. Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy.
Yannuzzi NA; Patel SN; Bhavsar KV; Sugiguchi F; Freund KB
Am J Ophthalmol; 2014 Aug; 158(2):319-327.e2. PubMed ID: 24814167
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal injection of anti-VEGF and diagnosis of primary intraocular central nervous system lymphoma.
Gambrelle J; Missotten G; Delhoum S; Desjardins L
J Fr Ophtalmol; 2013 May; 36(5):431-4. PubMed ID: 23306179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
